Learning Objectives:

1. Describe the main clinical features of AS and current therapeutic options.

2. Briefly review the JAK/STAT pathway and Janus kinase family of enzymes.

3. JAK inhibitors: promising for a wider spectrum of autoimmune diseases?

 

Session date: 
02/18/2020 - 8:30am to 9:30am CST
Location: 
UCMC N-002
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Marco A. Lopez-Velazquez